Open Payments

Massachusetts General Hospital

Type
Teaching hospital
Where
Boston, MA
Medicare CCN
220071
Received
$57,360,407 in 2,285 records, 2020 ($9,420,870 general, $47,939,537 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2020General payment391$9,420,870
2020Research payment1,894$47,939,537

By company

CompanyRecordsAmountYears
PFIZER INC.107$5,245,8562020
Amgen Inc.31$3,663,1252020
Biogen, Inc.29$3,258,0272020
Genentech, Inc.29$3,102,2022020
Merck Sharp & Dohme LLC170$2,451,2172020
GE HEALTHCARE21$2,446,4182020
Tanabe Pharma America, Inc.1$2,252,3092020
Boston Scientific Corporation58$2,154,3492020
Novo Nordisk Inc3$1,793,6582020
ABBVIE INC.102$1,722,4682020
E.R. Squibb & Sons, L.L.C.6$1,636,2012020
Beckman Coulter, Inc.6$1,625,1132020
Siemens Medical Solutions USA, Inc.70$1,591,4992020
AstraZeneca Pharmaceuticals LP13$1,334,2182020
Allergan, Inc.32$1,226,1892020
Stryker Corporation6$1,077,0202020
Boehringer Ingelheim International GmbH11$832,0782020
Takeda Pharmaceuticals U.S.A., Inc.82$775,5262020
Regeneron Pharmaceuticals, Inc.30$688,0722020
VERTEX PHARMACEUTICALS INCORPORATED7$653,1292020
LEO Pharma AS5$609,2902020
Eli Lilly and Company12$564,4002020
Zimmer Biomet Holdings, Inc.20$540,4902020
Alcon Research LLC22$518,6002020
Astellas Pharma Inc3$511,9752020
Biohaven Pharmaceuticals, Inc.6$461,7422020
SANOFI US SERVICES INC.13$445,9772020
Philips North America LLC18$429,0212020
Abbott Laboratories123$426,6332020
Kite Pharma, Inc.2$413,7802020
Olympus Corporation1$389,1102020
Intuitive Surgical Operations, Inc.25$376,2092020
Janssen Scientific Affairs, LLC4$363,0412020
Janssen Research & Development, LLC39$362,7142020
Medical Device Business Services, Inc.22$362,0802020
PTC Therapeutics, Inc.24$361,5592020
Novartis Pharmaceuticals Corporation14$354,0622020
F. Hoffmann-La Roche AG8$310,8662020
Bayer Healthcare Pharmaceuticals Inc.11$302,2542020
Gilead Sciences, Inc.23$300,0612020
KCI USA, Inc.2$300,0002020
OMNIlife science, Inc4$299,7562020
Agios Pharmaceuticals, Inc.2$293,6122020
Edwards Lifesciences Corporation15$288,7412020
Otsuka Pharmaceutical Development & Commercialization, Inc.5$277,0382020
Heidelberg Engineering, Inc.6$264,5832020
KARL STORZ Endoscopy-America2$258,8692020
Brahms GmbH5$256,7312020
Akcea Therapeutics, Inc.3$253,7552020
Medtronic Vascular, Inc.70$251,9732020

By nature of payment

NatureRecordsAmount
Research payment1,894$47,939,537
Royalty or License140$5,881,702
Grant31$1,415,971
Compensation for services other than consulting, including serving as faculty or as a speaker at a v67$801,072
Gift70$438,775
Education41$403,059
Consulting Fee17$373,780
Space rental or facility fees (teaching hospital only)18$82,850
Charitable Contribution7$23,660

Records

DateCompanyAmountNatureFormProductStudyYear
2020-12-31Haemonetics Corporation$32,200Research paymentIn-kind items and servicesTEG Device, DevicesUtilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vas2020
2020-12-31Intuitive Surgical, Inc.$29,000EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Siemens Medical Solutions USA, Inc.$26,295Research paymentCash or cash equivalentAI Rad Companion investigation2020
2020-12-31Siemens Medical Solutions USA, Inc.$22,203Research paymentCash or cash equivalentMAGNETOM Skyra Device, MR - MRIMGH2012MR6000wald2020
2020-12-31Haemonetics Corporation$19,320Research paymentIn-kind items and servicesTEG Device, DevicesUtilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vas2020
2020-12-31VASCULAR SOLUTIONS, INC.$18,790Research paymentIn-kind items and servicesInterventional Products Device, Interventional AccessCTO-PCI2020
2020-12-31Siemens Medical Solutions USA, Inc.$18,729Research paymentCash or cash equivalentsyngo X Workplace Device, AT - Fixed interventional x-ray/angiography fluoroscopyMGH Patel Neurosurgery Clinical AT2020
2020-12-31VASCULAR SOLUTIONS, INC.$16,857Research paymentIn-kind items and servicesInterventional Products Device, Interventional AccessCTO-PCI2020
2020-12-31Intuitive Surgical, Inc.$15,000EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Roche Diagnostics Operations, Inc.$14,039Research paymentCash or cash equivalentCD cobas Reagents Device, Centralized DiagnosticsECH16, RMJ20, RD0023762020
2020-12-31Intuitive Surgical, Inc.$13,080EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Haemonetics Corporation$12,000Research paymentIn-kind items and servicesTEG Device, DevicesUtilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vas2020
2020-12-31Siemens Medical Solutions USA, Inc.$12,000Research paymentCash or cash equivalentMGHVan der KouweNeuroClinicalMR2020
2020-12-31Siemens Medical Solutions USA, Inc.$10,622Research paymentCash or cash equivalentMGHSinghIRClinicalCR2020
2020-12-31Haemonetics Corporation$9,600Research paymentIn-kind items and servicesTEG Device, DevicesUtilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vas2020
2020-12-31Haemonetics Corporation$9,600Research paymentIn-kind items and servicesTEG Device, DevicesUtilization of Thromboelastography to Predict Arterial Thromboembolic Events in Revascularized Trauma and Peripheral Vas2020
2020-12-31Siemens Medical Solutions USA, Inc.$9,469Research paymentCash or cash equivalentResearch Fellows in Fast Body MR2020
2020-12-31Siemens Medical Solutions USA, Inc.$6,188Research paymentCash or cash equivalentMGH2019MRIPR932IPR991IPR963Gee2020
2020-12-31VASCULAR SOLUTIONS, INC.$6,095Research paymentIn-kind items and servicesInterventional Products Device, Interventional AccessCTO-PCI2020
2020-12-31Siemens Medical Solutions USA, Inc.$6,000Research paymentCash or cash equivalentMGH2018MRIPR818KWu2020
2020-12-31Edwards Lifesciences Corporation$5,978Research paymentCash or cash equivalentCLASP IID 2018-072020
2020-12-31Siemens Medical Solutions USA, Inc.$5,250Research paymentCash or cash equivalentMGHHuangNeuroClinicalMR2020
2020-12-31Medline Industries LP$5,100Research paymentCash or cash equivalent4 ART Cartridges2020
2020-12-31Siemens Medical Solutions USA, Inc.$4,324Research paymentCash or cash equivalentMGHPolimeni7TNeuroMR20202020
2020-12-31AstraZeneca Pharmaceuticals LP$3,938Research paymentIn-kind items and servicesFASENRA Drug, RespiratoryA Multicenter Randomized Double Blind Parallel Group Placebo Controlled Phase 3 Efficacy and Safety Study Of Benralizuma2020
2020-12-31Stryker Corporation$3,920GiftCash or cash equivalentNONE Device, NONE2020
2020-12-31Siemens Medical Solutions USA, Inc.$3,912Research paymentCash or cash equivalentMGH2014MRIPR900LausanneBrainImagingPolimeni2020
2020-12-31Siemens Medical Solutions USA, Inc.$3,662Research paymentCash or cash equivalentMGH2020MRIPR926Mojtahed2020
2020-12-31Siemens Medical Solutions USA, Inc.$3,200Research paymentCash or cash equivalentMGH2011MR0500Andronesi2020
2020-12-31Siemens Medical Solutions USA, Inc.$3,000Research paymentCash or cash equivalentteamplay images investigation2020
2020-12-31Intuitive Surgical, Inc.$2,680EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Intuitive Surgical, Inc.$2,500EducationIn-kind items and servicesDa Vinci Surgical System Device, SURGERY2020
2020-12-31Siemens Medical Solutions USA, Inc.$2,438Research paymentCash or cash equivalentMAGNETOM Prisma Device, MR - MRIMGHNguyenCardioClinicalMR2020
2020-12-31Siemens Medical Solutions USA, Inc.$2,281Research paymentCash or cash equivalentMGHGhoshhajraCardiacClinicalCT2020
2020-12-31Siemens Medical Solutions USA, Inc.$2,063Research paymentCash or cash equivalentMGH2018MRIPR992991Montesi2020
2020-12-31Masimo Corporation$2,036EducationIn-kind items and servicesrainbow Acoustic Monitoring Device, Devices2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,875Research paymentCash or cash equivalentMGH2019MRIPR1007Polimeni2020
2020-12-31Medartis Inc.$1,761GiftIn-kind items and servicesAPTUS Device, ORTHO2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,707Research paymentCash or cash equivalentMGH2020MRIPR991992Montesi2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,688Research paymentCash or cash equivalentMGH2019MRIPR899Hadjikhani2020
2020-12-31Masimo Corporation$1,685EducationIn-kind items and servicesEMMA and ISA Device, Devices2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,464Research paymentCash or cash equivalentMGH2020MRIPR932963991Gee2020
2020-12-31Siemens Medical Solutions USA, Inc.$1,277Research paymentCash or cash equivalentMGH2019MRIPR992Harisinghani2020
2020-12-31bioMerieux Inc$787GiftIn-kind items and servicesMINIVIDAS Device, Diagnostics2020
2020-12-31Siemens Medical Solutions USA, Inc.$750Research paymentCash or cash equivalentMGH2019MRIPR917Nguyen2020
2020-12-31Siemens Medical Solutions USA, Inc.$750Research paymentCash or cash equivalentMGH2018MR3200Catana2020
2020-12-31Siemens Medical Solutions USA, Inc.$655Research paymentCash or cash equivalentMGH2020MRIPR963991Gee2020
2020-12-31Masimo Corporation$594EducationIn-kind items and servicesrainbow Acoustic Monitoring Device, Devices2020
2020-12-31Siemens Medical Solutions USA, Inc.$588Research paymentCash or cash equivalentMGH2020MRIPR9251099Williams2020
2020-12-31Siemens Medical Solutions USA, Inc.$469Research paymentCash or cash equivalentMGH2017MRIPR911Kirsch2020
2020-12-31Allergan, Inc.$450Research paymentIn-kind items and servicesClinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3)2020
2020-12-31Siemens Medical Solutions USA, Inc.$413Research paymentCash or cash equivalentMGH2018MRIPR963996Catalano2020
2020-12-31Siemens Medical Solutions USA, Inc.$407Research paymentCash or cash equivalentMGH2020MRIPR8591323Ratai2020
2020-12-31Siemens Medical Solutions USA, Inc.$375Research paymentCash or cash equivalentMGH2019MRIPR1080Polimeni2020
2020-12-31Siemens Medical Solutions USA, Inc.$350Research paymentCash or cash equivalentMGH2017MRIPR992991Montesi2020
2020-12-31Masimo Corporation$321EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-31Siemens Medical Solutions USA, Inc.$283Research paymentCash or cash equivalentMGH2020MRIPR925Polimeni2020
2020-12-31Siemens Medical Solutions USA, Inc.$167Research paymentCash or cash equivalentMGH2018MRIPR1105Polimeni2020
2020-12-31Zimmer Biomet Holdings, Inc.$149GiftIn-kind items and servicesZimmer Biomet Instruments and Implants Device, General2020
2020-12-31Masimo Corporation$24EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-31Aimmune Therapeutics, Inc.$18Research paymentCash or cash equivalentPALFORZIA Biological, ALLERGYA MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS 2020
2020-12-30KCI USA, Inc.$150,000Royalty or LicenseCash or cash equivalentCELLUTOME Device, DEVICES2020
2020-12-30KCI USA, Inc.$150,000Royalty or LicenseCash or cash equivalentCELLUTOME Device, DEVICES2020
2020-12-30Clinisys, Inc.$37,697Royalty or LicenseCash or cash equivalent2020
2020-12-30ABBVIE INC.$1,634Research paymentCash or cash equivalentSKYRIZI Biological, IMMUNOLOGYM15-9972020
2020-12-30Penumbra, Inc.$1,462Research paymentCash or cash equivalentPenumbra SMART Coil Device, NeurointerventionSURF2020
2020-12-29Incyte Corporation$68,689Research paymentCash or cash equivalentA Phase II trial of INCMGA00012 in patients with previously treated advanced or metastatic adenosquamous pancreatic canc2020
2020-12-29United Therapeutics Corporation$2,549Research paymentCash or cash equivalentTYVASO Drug, PAHA MULTICENTER RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INHALED TREPROST2020
2020-12-29United Therapeutics Corporation$2,058Research paymentCash or cash equivalentTYVASO Drug, PAHAN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DI2020
2020-12-29Pacira Pharmaceuticals Incorporated$1,670Research paymentIn-kind items and servicesEXPAREL Drug, PAIN MANAGEMENTA PHASE 3, RANDOMIZED, DOUBLE BLINDED, ACTIVE CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMA2020
2020-12-28Biohaven Pharmaceuticals, Inc.$30,836Research paymentCash or cash equivalentA Phase IIb/III, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult Subjects with Spinocerebella2020
2020-12-28PFIZER INC.$17,784Research paymentCash or cash equivalentNEUROSCIENCE RESEARCH UNIT PROJECT2020
2020-12-28PFIZER INC.$17,783Research paymentCash or cash equivalentNEUROSCIENCE RESEARCH UNIT PROJECT2020
2020-12-28PFIZER INC.$17,783Research paymentCash or cash equivalentNEUROSCIENCE RESEARCH UNIT PROJECT2020
2020-12-28Nihon Kohden America, LLC$5,819Royalty or LicenseCash or cash equivalent2020
2020-12-28Janssen Research & Development, LLC$995Research paymentCash or cash equivalentA long-term, multicenter, single-arm, open-label extension of the SERENADE study, to assess the safety and efficacy of m2020
2020-12-24Regeneron Pharmaceuticals, Inc.$3,037Research paymentCash or cash equivalentDUPIXENT Biological, INFLAMMATION AND IMMUNOLOGYA PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY IN PEDIATRIC SUBJECTS WITH PEANUT ALLERGY TO2020
2020-12-24Intercept Pharmaceuticals, Inc.$928Research paymentCash or cash equivalent10097422020
2020-12-23Agios Pharmaceuticals, Inc.$172,920Research paymentCash or cash equivalentTIBSOVO Drug, OncologySponsored Research Agreement2020
2020-12-23Edwards Lifesciences Corporation$7,625Research paymentCash or cash equivalentCLASP II TR Pivotal, Study No. 2019-072020
2020-12-23Edwards Lifesciences Corporation$7,371Research paymentCash or cash equivalentCLASP IIF (2018-07)2020
2020-12-23Gilead Sciences, Inc.$2,389Research paymentCash or cash equivalentA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilof2020
2020-12-23Masimo Corporation$2,333EducationIn-kind items and servicesrainbow Acoustic Monitoring Device, Devices2020
2020-12-23Masimo Corporation$919EducationIn-kind items and servicesSET and rainbow SET Device, Devices2020
2020-12-22Boston Scientific Corporation$462,022Research paymentCash or cash equivalentWATCHMAN Device, STRUCTURAL HEARTNeuro AF Study2020
2020-12-22Radius Health, Inc.$176,884Research paymentCash or cash equivalentDissecting differences between abaloparatide and teriparatide signaling in bone cells2020
2020-12-22Genentech, Inc.$154,845Research paymentCash or cash equivalentActemra Biological, ImmunologyTOCILIZUMAB PLUS A SHORT PREDNISONE TAPER FOR GIANT CELL ARTERITIS2020
2020-12-22Bayer Healthcare Pharmaceuticals Inc.$93,696Research paymentCash or cash equivalentNexavar Drug, Oncology2020
2020-12-22UCB SA$72,936Research paymentCash or cash equivalent2020
2020-12-22Boston Scientific Corporation$55,353Research paymentCash or cash equivalentGENERAL - THERAPIES Device, THERAPIESSmartphone based coronary artery disease management2020
2020-12-22IRONWOOD PHARMACEUTICALS, INC$1,831Research paymentCash or cash equivalentC3718-3012020
2020-12-22Novo Nordisk AS$1,095Research paymentCash or cash equivalentNN9536-44512020
2020-12-22Takeda Pharmaceuticals U.S.A., Inc.$325Research paymentCash or cash equivalentAN OBSERVATIONAL, NON-INTERVENTIONAL, STUDY OF PATIENTS WITH HEREDITARY ANGIOEDEMA IN THE UNITED STATES AND CANADA (EMPO2020
2020-12-22CSL Behring$126Research paymentIn-kind items and servicesA Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody2020
2020-12-21Biogen, Inc.$138,338Research paymentCash or cash equivalentDigital Quantitative Measurements in ALS2020
2020-12-21Travere Therapeutics, Inc.$25,342Research paymentCash or cash equivalent024PKAN150042020
2020-12-21Janssen Research & Development, LLC$17,165Research paymentCash or cash equivalentA randomized, double blind, multicenter, placebo controlled study to evaluate safety and efficacy and tolerability of es2020
2020-12-21Merck Sharp & Dohme LLC$755Research paymentIn-kind items and servicesMK-7339 Drug, ONCOLOGYAn Open-label, Randomized, Phase 2,3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After I2020
2020-12-18W. L. Gore & Associates, Inc.$3,961Research paymentCash or cash equivalentProduct in Development Device, DevicesGORE CARDIOFORM ASD Occluder Clinical Study: A Study to evaluate safety and efficacy in the treatment of transcatheter c2020
2020-12-18Medtronic Vascular, Inc.$2,832Research paymentCash or cash equivalentViva Device, Implantable Cardioverter Defibrillators (ICDs)AdaptResponse2020
2020-12-18Medical Device Business Services, Inc.$1,750Research paymentCash or cash equivalentA Multi-center, Prospective, Single Arm Study of Patients Undergoing a Two or Three Level ACDF Using ViviGen Cellular Bo2020
2020-12-18W. L. Gore & Associates, Inc.$1,500Research paymentCash or cash equivalentCarotid Stent Device, DevicesGORE Carotid Stent Clinical Study for the treatment of carotid artery stenosis in patients at increased risk for adverse2020
2020-12-18Medical Device Business Services, Inc.$962Research paymentCash or cash equivalentSafety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptoma2020
2020-12-18Incyte Corporation$59Research paymentCash or cash equivalentA Phase II trial of INCMGA00012 in patients with previously treated advanced or metastatic adenosquamous pancreatic canc2020
2020-12-17GW Research Limited$85,000GrantCash or cash equivalentEpidiolex Drug, Neurology2020
2020-12-17ABBVIE INC.$85,000Research paymentCash or cash equivalentDEPAKOTE Drug, NEUROSCIENCE2020
2020-12-17Biogen, Inc.$66,020Research paymentCash or cash equivalentClinic and home speech and coordination measurement in spinocerebellar ataxias and multiple system atrophy2020
2020-12-17ABBVIE INC.$12,471Research paymentCash or cash equivalentM15-5702020
2020-12-17Roche Products Limited$4,138Research paymentCash or cash equivalentOCREVUS Biological, ImmunologyOBSERVATIONAL STUDY OF OCRELIZUMAB TREATED MULTIPLE SCLEROSIS PATIENTS US COMMITMENT2020
2020-12-17Biohaven Pharmaceuticals, Inc.$3,430Research paymentCash or cash equivalentA Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of BHV-3241 in2020
2020-12-17Janssen Research & Development, LLC$1,755Research paymentCash or cash equivalentA Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Ad2020
2020-12-17ABBVIE INC.$1,614Research paymentCash or cash equivalentLUPRON DEPOT Drug, ENDOCRINOLOGYM16-9042020
2020-12-17Abbott Laboratories$656Research paymentCash or cash equivalentMitraClip Device, VascularCardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitr2020
2020-12-16ABBVIE INC.$85,000Research paymentCash or cash equivalentDEPAKOTE Drug, NEUROSCIENCE2020
2020-12-16Merck Sharp & Dohme LLC$13,000Research paymentCash or cash equivalentMK-5475 Drug, CARDIOVASCULARA Study to Assess the Safety, Tolerability, and Pharmacodynamics of Multiple Dose MK-5475 in Participants with Hypoxemia2020
2020-12-16Intercept Pharmaceuticals, Inc.$7,471Research paymentCash or cash equivalentOCALIVA Drug, HEPATOLOGY GASTROENTEROLOGY10118662020
2020-12-16AstraZeneca Pharmaceuticals LP$1,000GrantCash or cash equivalent2020
2020-12-16Merck Sharp & Dohme LLC$749Research paymentIn-kind items and servicesMK-8189 Drug, NEUROSCIENCEA Phase 2B Randomized, Double-Blind, Placebo- and Active-Controlled Trial of the Efficacy and Safety of MK-8189 in Parti2020
2020-12-16Surmodics, Inc.$300Research paymentCash or cash equivalentAVess FIH Device, Drug-Coated BalloonAVess FIH2020
2020-12-16Blueprint Medicines Corporation$100Charitable ContributionCash or cash equivalent2020
2020-12-15Biohaven Pharmaceuticals, Inc.$216,481Research paymentCash or cash equivalentEfficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder2020
2020-12-15MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC.$214,884Research paymentCash or cash equivalentFEASIBILITY AND SENSITIVITY OF A SYMPTOM MONITORING APPLICATION IN REAL TIME (SMART) IN ALS2020
2020-12-15Biohaven Pharmaceuticals, Inc.$185,436Research paymentCash or cash equivalentEfficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder2020
2020-12-15Allergan, Inc.$47,640Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMI2020
2020-12-15Allergan, Inc.$45,263Research paymentCash or cash equivalentA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMI2020
2020-12-15Amgen Inc.$22,275Royalty or LicenseCash or cash equivalent2020
2020-12-15NIDEK CO., LTD.$20,000Royalty or LicenseCash or cash equivalent2020
2020-12-15PFIZER INC.$4,131Research paymentCash or cash equivalentA LONGTERM OPEN LABEL EXTENSION STUDY OF PF06651600 FOR THE TREATMENT OF ALOPECIA AREATA2020
2020-12-15Takeda Pharmaceuticals U.S.A., Inc.$2,300Space rental or facility fees (teaching hospital only)Cash or cash equivalent2020
2020-12-15Abbott Laboratories$1,116Research paymentCash or cash equivalentXience Sierra Coronary Stent System Device, VascularXIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients2020
2020-12-15Incyte Corporation$59Research paymentCash or cash equivalentA Phase II trial of INCMGA00012 in patients with previously treated advanced or metastatic adenosquamous pancreatic canc2020
2020-12-14Biohaven Pharmaceuticals, Inc.$25,486Research paymentCash or cash equivalentHEALEY ALS Platform Trial - Regimen B Verdiperstat2020
2020-12-14Zogenix Inc.$22,000GrantCash or cash equivalent2020
2020-12-14Bayer Healthcare Pharmaceuticals Inc.$7,500Research paymentCash or cash equivalentNon-CoveredBay1002670 Endometriosis Dose finding EU & US JP CN2020
2020-12-14EMD Serono, Inc.$1,690Research paymentCash or cash equivalentAtacicept Biological, ImmunologyA Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Atacicept in IgA N2020
2020-12-14Bayer Healthcare Pharmaceuticals Inc.$689Research paymentCash or cash equivalentAdempas Drug, Cardio-pulmonaryBAY 63-2521 ph II LVD-assoc.-PH2020
2020-12-14EMD Serono, Inc.$125Research paymentCash or cash equivalentAtacicept Biological, ImmunologyA Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Atacicept in IgA N2020
2020-12-11PFIZER INC.$63,346Research paymentIn-kind items and servicesBAVENCIO Drug, ONCOLOGYA PHASE 2 TWOGROUP TWOSTAGE OPENLABEL STUDY OF AVELUMAB MSB0010718C IN PATIENTS WITH MSS MSIH AND POLEMUTATED RECURRENT 2020
2020-12-11PTC Therapeutics, Inc.$50,000Royalty or LicenseCash or cash equivalent2020
2020-12-11Medtronic Vascular, Inc.$1,500Research paymentCash or cash equivalentHeartWare HVAD Device, Ventricular Assist DevicesDT PAS2020
2020-12-10Aesculap, Inc.$114,854GiftCash or cash equivalent2020
2020-12-10E.R. Squibb & Sons, L.L.C.$50,000Research paymentCash or cash equivalentSystems Serology Analysis to Define Biomarkers for Check Point Inhibition Melanoma2020
2020-12-10Medical Device Business Services, Inc.$15,000GrantCash or cash equivalent2020
2020-12-10Abbott Laboratories$7,500Research paymentCash or cash equivalentMitraClip Device, Cardiac Arrhythmias and Heart FailurePercutaneous MitraClipTM Device or Surgical Mitral Valve REpair in PAtients with PrImaRy MItral Regurgitation who are Ca2020
2020-12-10Abbott Laboratories$5,000Research paymentCash or cash equivalentHeartMate 3 Left Ventricular Dev Device, Cardiac Arrhythmias and Heart FailureAntiplatelet Removal and HemocompatIbility Events in the HeartMate 3 Pump2020
2020-12-10Medtronic, Inc.$4,619Research paymentCash or cash equivalentAttain Device, LeadsPSR-CVG2020
2020-12-10Aesculap, Inc.$3,125GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$2,865GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$2,014GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$1,414GiftCash or cash equivalent2020
2020-12-10LivaNova USA, Inc.$1,137Research paymentCash or cash equivalentVNS Therapy Device, Cardiology/Vascular DiseasesA Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Thera2020
2020-12-10Medtronic, Inc.$1,107Research paymentCash or cash equivalentAttain Device, LeadsPSR-CVG2020
2020-12-10Regeneron Pharmaceuticals, Inc.$987Research paymentCash or cash equivalentAN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYP2020
2020-12-10Aesculap, Inc.$905GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$852GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$670GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$610GiftCash or cash equivalent2020
2020-12-10Medtronic, Inc.$592Research paymentCash or cash equivalentAttain Device, LeadsPSR-CVG2020
2020-12-10Aesculap, Inc.$530GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$213GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$148GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$96GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$80GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$79GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$71GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$70GiftCash or cash equivalent2020
2020-12-10Aesculap, Inc.$60GiftCash or cash equivalent2020
2020-12-10Medtronic, Inc.$52Research paymentCash or cash equivalentAttain Device, LeadsPSR-CVG2020
2020-12-10Aesculap, Inc.$40GiftCash or cash equivalent2020
2020-12-09Intuitive Surgical Operations, Inc.$300,000Research paymentCash or cash equivalentDa Vinci Surgical System Device, SURGERYOptically-Subsampled Optical Coherence Tomography ("OS-OCT")2020
2020-12-09Takeda Pharmaceuticals U.S.A., Inc.$14,575Research paymentCash or cash equivalent2020
2020-12-09Stryker Corporation$4,402Royalty or LicenseCash or cash equivalentMAKO Device, KNEES, HIPS2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$3,263Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Clinical Trial of Pembrolizumab MK-3475 Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors KEYNOT2020
2020-12-09Merck Sharp & Dohme LLC$55Research paymentIn-kind items and servicesKEYTRUDA Biological, ONCOLOGYA Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab MK-3475 versus Placebo as A2020
2020-12-08Novartis Pharmaceuticals Corporation$19,843Consulting FeeCash or cash equivalentENTRESTO Drug, CARDIOVASCULAR2020
2020-12-08Alexion Pharmaceuticals, Inc.$12,446Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and 2020
2020-12-08Alexion Pharmaceuticals, Inc.$5,058Research paymentCash or cash equivalentUltomiris Drug, ImmunologyA Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Rav2020
2020-12-08ABBVIE INC.$1,323Research paymentCash or cash equivalentM15-5702020
2020-12-08BIOTRONIK INC.$476Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$476Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$476Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$476Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$476Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$393Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$393Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$393Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$393Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$210Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$210Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$210Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$110Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$110Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$110Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$82Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020
2020-12-08BIOTRONIK INC.$82Research paymentCash or cash equivalentOrsiro Device, Cardiology/Vascular DiseasesBIOFLOW-VII2020

The latest 200 records of 2,285.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Suffolk CountyBoston city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Boston, MA, county Suffolk County, MA, state Massachusetts; placed by its city name.

MeasurePlace (city or town)
Boston, MA
County
Suffolk County, MA
State
Massachusetts
Population B01003666,442785,1217,044,056
Population, 2020 census P1675,647797,9367,029,917
Median age B0100233.333.940.0
Under 18 B0100115.1%16.0%19.4%
65 and over B0100113.0%13.3%17.9%
Households B11001283,374327,1672,785,042
Foreign born B0500227.8%29.8%18.0%
Median household income B19013$97,344$95,631$103,960
Median family income B19113$116,436$112,072$131,675
Per capita income B19301$61,698$58,636$57,897
Poverty rate B1700116.6%16.2%10.0%
Unemployment rate B230256.1%6.3%5.2%
Civilian labor force B23025402,354468,6363,911,446
Mean commute (minutes) B0801330.330.929.1
Bachelor's degree or higher B1500354.9%50.6%47.3%
Housing units B25001310,625357,2903,030,406
Owner-occupied B2500335.7%36.5%62.5%
Renters B2500364.3%63.5%37.5%
Median home value B25077$731,700$705,800$562,100
Median gross rent B25064$2,147$2,129$1,762
White, not Hispanic B0300244.1%43.6%66.6%
Black B0300219.3%17.1%6.4%
Hispanic or Latino B0300219.3%23.2%13.3%
Asian B0300210.3%9.2%7.3%
American Indian and Alaska Native B030020.1%0.1%0.1%

Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); Unemployment rate: 3.8% in Sep 2016 to 4.3% in Sep 2026; low 3.0%, high 17.8% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Boston, MA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.